靶向白血病的“脂肪牙”。
Targeting leukemia's "fatty tooth".
机构信息
CENTRE FOR DRUG RESEARCH AND DEVELOPMENT;
THE UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER.
出版信息
Blood. 2015 Oct 15;126(16):1874-5. doi: 10.1182/blood-2015-08-665125.
PMID:26472736
Abstract
In this issue of Blood, Ricciardi et al report a novel fatty acid oxidation (FAO) inhibitor, ST1326, that effectively inhibits proliferation, survival, and chemoresistance in leukemia cell lines and primary samples.
摘要
在本期《Blood》中，Ricciardi 等人报告了一种新型脂肪酸氧化 (FAO) 抑制剂 ST1326，它能有效抑制白血病细胞系和原代样本的增殖、存活和化疗耐药性。
Zotero 插件